We are live on ! Find out more
HighTower Advisors

HighTower Advisors Portfolio holdings

AUM $94.2B
1-Year Est. Return 21.24%
This Fund
S&P 500
This Quarter Est. Return
+3.29%
1 Year Est. Return
+21.24%
3 Year Est. Return
+66.34%
5 Year Est. Return
+83.36%
10 Year Est. Return
+290.31%
AUM
$16.8B
AUM Growth
+$1.83B
Cap. Flow
+$1.36B
Cap. Flow %
8.07%
Top 10 Hldgs %
16.18%
Holding
2,596
New
303
Increased
1,155
Reduced
772
Closed
222

Sector Composition

Rank Sector Weight
1 Technology 10.43%
2 Financials 9.02%
3 Healthcare 8.2%
4 Energy 6.96%
5 Industrials 6.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IFGL icon
1376
iShares International Developed Real Estate ETF
IFGL
$81.6M
$669K ﹤0.01%
22,484
-68,054
-75% -$2.03M
PS
1377
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
$669K ﹤0.01%
21,979
-2,247
-9% -$72.2K
SNAP icon
1378
Snap
SNAP
$7.32B
$668K ﹤0.01%
47,314
-13,089
-22% -$160K
CPB icon
1379
Campbell Soup
CPB
$6.51B
$667K ﹤0.01%
16,640
+2,920
+21% +$115K
MYN icon
1380
BlackRock MuniYield New York Quality Fund
MYN
$374M
$667K ﹤0.01%
52,457
-2,215
-4% -$27.8K
GNCA
1381
DELISTED
Genocea Biosciences, Inc.
GNCA
$666K ﹤0.01%
169,735
+126,347
+291% +$659K
TRN icon
1382
Trinity Industries
TRN
$2.97B
$663K ﹤0.01%
31,908
-314
-1% -$6.68K
NEM icon
1383
Newmont
NEM
$98.2B
$657K ﹤0.01%
17,000
+3,753
+28% +$127K
FDIS icon
1384
Fidelity MSCI Consumer Discretionary Index ETF
FDIS
$1.59B
$656K ﹤0.01%
14,283
+4,549
+47% +$205K
HLI icon
1385
Houlihan Lokey
HLI
$9.68B
$655K ﹤0.01%
14,703
+4,946
+51% +$231K
ALXN
1386
DELISTED
Alexion Pharmaceuticals
ALXN
$655K ﹤0.01%
4,976
+358
+8% +$46.1K
EMLC icon
1387
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.74B
$654K ﹤0.01%
18,901
+332
+2% +$11.1K
APTV icon
1388
Aptiv
APTV
$12B
$652K ﹤0.01%
8,109
+109
+1% +$8.63K
TY icon
1389
TRI-Continental Corp
TY
$1.86B
$652K ﹤0.01%
24,208
-1,478
-6% -$39.5K
FNB icon
1390
FNB Corp
FNB
$6.78B
$651K ﹤0.01%
55,205
-184
-0.3% -$2.12K
GWW icon
1391
W.W. Grainger
GWW
$65.3B
$650K ﹤0.01%
2,415
-141
-6% -$39.6K
GEN
1392
DELISTED
Genesis Healthcare, Inc.
GEN
$649K ﹤0.01%
523,570
MKL icon
1393
Markel Group
MKL
$25B
$643K ﹤0.01%
589
+22
+4% +$23.1K
EMN icon
1394
Eastman Chemical
EMN
$7.8B
$642K ﹤0.01%
8,266
-28,768
-78% -$2.19M
WST icon
1395
West Pharmaceutical
WST
$23.1B
$642K ﹤0.01%
5,105
+372
+8% +$43.9K
EOT
1396
Eaton Vance National Municipal Opportunities Trust
EOT
$267M
$641K ﹤0.01%
28,188
AGCO icon
1397
AGCO
AGCO
$8.78B
$638K ﹤0.01%
8,230
-1,884
-19% -$134K
DWX icon
1398
State Street SPDR S&P International Dividend ETF
DWX
$521M
$637K ﹤0.01%
16,207
-996
-6% -$38.5K
INFO
1399
DELISTED
IHS Markit Ltd. Common Shares
INFO
$636K ﹤0.01%
10,090
+510
+5% +$29.3K
RHI icon
1400
Robert Half
RHI
$3.61B
$633K ﹤0.01%
11,104
+2,261
+26% +$135K

Similar funds

HighTower Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, HighTower Advisors held 2,596 positions worth $16.8B, up 12% from $15B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

HighTower Advisors deployed $1.36B of net new capital in Q2 2019, opening 303 new positions and adding to 1,155 existing holdings. Its largest new stake was Bain Capital Specialty: 644,584 shares worth $11.8M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 11% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was DuPont de Nemours, an estimated $16.2M trimmed.

  • HighTower Advisors's largest Q2 2019 buy was Bain Capital Specialty: 644,584 shares worth $11.8M.
  • HighTower Advisors added most to Vanguard FTSE Europe ETF in Q2 2019, an estimated $61.4M increase.
  • HighTower Advisors's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $16.2M.
  • HighTower Advisors fully exited Blackstone in Q2 2019, selling an estimated $60.4M.
  • HighTower Advisors's ten largest holdings make up 16% of its $16.8B portfolio in Q2 2019.
  • HighTower Advisors opened 303 new positions and closed 222 in Q2 2019.
  • HighTower Advisors's portfolio value rose 12% quarter-over-quarter to $16.8B.

Based on HighTower Advisors's 13F filing for Q2 2019, filed 13 Aug 2019.